Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Recruiting · NCT03769415 · Registry updated 2026-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-01-30 | NCT03769415 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Breast Cancer Research Foundation | 40 |
| UNC Lineberger Comprehensive Cancer Center | 125 |
| Veracyte, Inc. | 8 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 243 |
| UNC Rex Healthcare | Raleigh | United States | 4 |